EDMONTON, ALBERTA –November 14, 2012 – Following a press conference held yesterday with The Honourable Laurie Hawn, Member of Parliament for Edmonton Centre, Ceapro Inc. (CZO –V) (“Ceapro” or the Company”) is pleased to announce that it has signed a Letter of Intent with AAFC to collaborate in
Read more →EDMONTON, ALBERTA –August 7, 2012 – Ceapro Inc. (CZO –V) (“Ceapro” or the Company”) today announced its financial results for the three-month and six-month periods ended June 30, 2012. Second quarter 2012 corporate highlights Signing of a worldwide licensing agreement with Agriculture and Agri-Food Canada for a
Read more →EDMONTON, ALBERTA, Canada –(Marketwire-July 9, 2012) – Ceapro Inc. (“Ceapro”or the “Company”) (TSX VENTURE: CZO) announced that Motions carried at the Annual General Meeting of June 25, 2012 include the re-election of Board Members: Ed Taylor as Chairman, Gilles Gagnon, Don Oborowsky, Glenn Rourke, and John Zupancic
Read more →EDMONTON, ALBERTA–May 28, 2012 – Ceapro Inc. (CZO –V) (“Ceapro” or “the Company”) today released financial results for the quarter ended March 31, 2012 and provided a corporate update. PDF of Ceapro Reports First Quarter 2012 FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2012 Total sales of
Read more →EDMONTON, ALBERTA, Canada —May 16, 2012 — Ceapro Inc. (TSX-V CZO) is pleased to announce that Dr. Bernhard Seifried from Ceapro presented today the latest results obtained from one of Ceapro’s research programs using a supercritical drying technology. The presentation entitled “Supercritical Fluid Drying of High Molecular Weight Biopolymers for
Read more →EDMONTON, ALBERTA – May 8, 2012 – Ceapro Inc. (CZO –V) (“Ceapro” or the Company”) is pleased to announce that it has signed a licensing agreement with AAFC for the sole worldwide rights for all fields of use for an avenanthramide process technology. This innovative technology will
Read more →EDMONTON, ALBERTA–April 30, 2012 – Ceapro Inc. (CZO –V) (“Ceapro” or “the Company”) today released financial and operating results for the fiscal year ended December 31, 2011, its first annual financial report under IFRS . FINANCIAL RESULTS FOR THE FULL YEAR ENDED DECEMBER 31, 2011 Total sales
Read more →EDMONTON, ALBERTA – February 27, 2012 – Ceapro Inc. (CZO–V) (“Ceapro” or the Company”) is very pleased to announce the execution of an agreement with Alberta Innovates Bio Solutions who has awarded the Company a $1.6 million grant to establish a state of the art commercial scale
Read more →Edmonton, Alberta –February 10, 2012 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the “Company”) announced today it and its wholly owned subsidiary, Ceapro Technology Inc. (“CTI”), were served with a Statement of Claim filed in the Court of Queens Bench of Alberta by AVAC Ltd.
Read more →EDMONTON, ALBERTA, Canada —February 3, 2012 — Ceapro Inc. (TSX-V CZO) is pleased to announce that it has retained the services of Renmark Financial Communications Inc. to handle its investor relations activities. “We are pleased to announce that we have selected Renmark to reinforce Ceapro’s profile in
Read more →